Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNM antisense RNA 2 (SYNM-AS2)
- Target
- SYNM-AS2
- Molecular classification
- Antisense RNA, Long non-coding RNA (lncRNA), Other
01
Overview
SYNM antisense RNA 2 (SYNM-AS2, TP53LC11) is a long non-coding RNA transcribed antisense to the SYNM gene. Its precise biological function remains uncharacterized, but by analogy to other antisense RNAs, it may regulate SYNM or nearby gene expression via RNA-RNA or chromatin-based mechanisms. Antisense RNAs are increasingly recognized for their role in modulating transcription, RNA stability, and translation, particularly in the context of cancer and other gene-dosage disorders. However, SYNM-AS2 itself is not a validated therapeutic target, is not a receptor, enzyme, or transporter, and has not been implicated in direct drug interactions or biomarker-guided therapies. If you require information for structured databases, treat SYNM-AS2 as a regulatory non-coding RNA with limited characterization and do not map it as a traditional drug target. Further investigation or literature may be needed to clarify any disease association or regulatory role.
- Other names
- SYNM-AS2TP53LC11SYNM antisense RNA 2
02
Biological functions
Regulation of gene expression at transcriptional and/or post-transcriptional levelsPotential modulation of SYNM gene or TP53 cancer-related pathways (putative/inferred)
03
Disease associations
Cancer (possible role based on context and antisense RNA functions, but not directly established)Other (may act in gene dosage, expression regulation, but specific disease links not documented)
Beyond the preview
Go deeper on SYNM antisense RNA 2 (SYNM-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYNM antisense RNA 2 (SYNM-AS2).